Senseonics Launches Eversense 365, A One-Year Continuous Glucose Monitoring System in Europe
Senseonics Holdings, Inc. has announced the European launch of Eversense® 365, the first and only one-year continuous glucose monitoring (CGM) system. Following CE Mark approval, it is now available in Sweden, with upcoming launches in Germany, Spain, and Italy. Eversense 365 doubles sensor lifespan to one year, improves calibration frequency, and aims to enhance diabetes management for patients in Europe.
The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll out